Capricor Therapeutics Inc (CAPR)

Jan 06, 2026

(CAPR) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jan 06, 2026

Jan 05, 2026

Capricor Therapeutics (NASDAQ:CAPR) Shares Down 7.8%What's Next? - MarketBeat

Jan 05, 2026

Jan 05, 2026

‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win - MSN

Jan 05, 2026

Jan 05, 2026

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 05, 2026

Jan 03, 2026

Capricor Therapeutics (NASDAQ:CAPR) Upgraded at Wall Street Zen - MarketBeat

Jan 03, 2026

Dec 30, 2025

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 4.5%Here's What Happened - MarketBeat

Dec 30, 2025

Dec 30, 2025

Best Biotech Stocks To ConsiderDecember 7th - MarketBeat

Dec 30, 2025

Dec 30, 2025

HBK Sorce Advisory LLC Buys 42,951 Shares of Capricor Therapeutics, Inc. $CAPR - MarketBeat

Dec 30, 2025

Dec 27, 2025

Analyst Downgrade: How interest rate cuts could boost Capricor Therapeutics Inc stockWeekly Stock Analysis & Daily Profit Focused Stock Screening - moha.gov.vn

Dec 27, 2025

Dec 27, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Dec 27, 2025

Dec 26, 2025

(CAPR) Volatility Zones as Tactical Triggers - Stock Traders Daily

Dec 26, 2025

Dec 25, 2025

Trend Review: Why Capricor Therapeutics Inc. stock attracts high net worth investors2025 Buyback Activity & Safe Investment Capital Preservation Plans - moha.gov.vn

Dec 25, 2025

Dec 25, 2025

HBK Sorce Advisory LLC Raises Stake in Capricor Therapeutics, Inc. $CAPR - MarketBeat

Dec 25, 2025

Dec 25, 2025

Short Interest in Capricor Therapeutics, Inc. (NASDAQ:CAPR) Decreases By 69.4% - MarketBeat

Dec 25, 2025

Dec 24, 2025

Gene therapy genie back in the bottle? - BioWorld MedTech

Dec 24, 2025

Dec 24, 2025

Capricor Therapeutics prices $150M stock offering - MSN

Dec 24, 2025

Dec 23, 2025

Capricor Therapeutics (CAPR) price target increased by 32.98% to 51.82 - MSN

Dec 23, 2025

Dec 22, 2025

Top Medical Stocks To ResearchDecember 3rd - MarketBeat

Dec 22, 2025

Dec 22, 2025

Assessing Capricor Therapeutics (CAPR) Valuation After Positive HOPE-3 Data and Nippon Shinyaku Commercialization Deal - Sahm

Dec 22, 2025

Dec 21, 2025

Capricor Therapeutics launches proposed public offering of common stock - MSN

Dec 21, 2025

Dec 20, 2025

Earnings Risk: Is ARK Autonomous Technology & Robotics stock cheap by valuation metricsMarket Trend Summary & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn

Dec 20, 2025

Dec 20, 2025

Why Capricor Therapeutics Inc. stock attracts high net worth investors2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда

Dec 20, 2025

Dec 20, 2025

How Capricor Therapeutics Inc. (4LN2) stock trades pre earningsQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru

Dec 20, 2025

Dec 20, 2025

Does Capricor Therapeutics Inc. stock trade at a discount to peers2025 Analyst Calls & Advanced Technical Signal Analysis - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.8%What's Next? - MarketBeat

Dec 19, 2025

Dec 19, 2025

Capricor Therapeutics (STU:4LN2) EV-to-OCF : -21.03 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Dec 19, 2025

Capricor Therapeutics (STU:4LN2) EV-to-FCF : -18.80 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Dec 19, 2025

Can Capricor Therapeutics Inc. stock reach $100 price target2025 Pullback Review & Weekly Sector Rotation Insights - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Why Capricor Therapeutics Inc. (4LN2) stock is a strong analyst pick2025 Bull vs Bear & Low Drawdown Investment Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

CAPR stock price: Why is Capricor Therapeutics stock surging over 293% today? - MSN

Dec 19, 2025

Dec 19, 2025

Can Capricor Therapeutics Inc. (4LN2) stock double in coming years2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

How Capricor Therapeutics Inc. stock reacts to global recession fears2025 Risk Factors & Weekly Stock Breakout Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

How Capricor Therapeutics Inc. (4LN2) stock benefits from digital adoptionRecession Risk & Target Return Focused Stock Picks - Улправда

Dec 18, 2025

Dec 18, 2025

Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory - Insider Monkey

Dec 18, 2025

Dec 18, 2025

Is Capricor Therapeutics Inc. stock attractive for long term wealth building2025 Price Targets & Smart Investment Allocation Tips - Улправда

Dec 18, 2025

Dec 17, 2025

Transcript : Capricor Therapeutics, Inc.Special Call - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Piper Sandler reiterates Capricor stock rating, names it 2026 top pick - Investing.com UK

Dec 17, 2025

Dec 16, 2025

PPMD to host webinar on Capricor’s DMD therapy trial results By Investing.com - Investing.com Canada

Dec 16, 2025

Dec 16, 2025

Capricor Therapeutics Announces Community Webinar on Positive HOPE-3 Trial Results for Deramiocel in Duchenne Muscular Dystrophy - Quiver Quantitative

Dec 16, 2025

Dec 16, 2025

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy - The Manila Times

Dec 16, 2025

Dec 16, 2025

Capricor Therapeutics and Parent Project Muscular Dystrophy - GlobeNewswire

Dec 16, 2025

Dec 15, 2025

CAPR: B. Riley Securities Raises Target Price to $50, Maintains Buy Rating | CAPR Stock News - GuruFocus

Dec 15, 2025

Dec 15, 2025

B. Riley Adjusts Price Target on Capricor Therapeutics to $50 From $21, Maintains Buy Rating - marketscreener.com

Dec 15, 2025

Dec 14, 2025

Understanding the Setup: (CAPR) and Scalable Risk - news.stocktradersdaily.com

Dec 14, 2025

Dec 14, 2025

Capricor Therapeutics (CAPR): Reassessing Valuation After Positive Phase 3 HOPE-3 Results for Deramiocel - Sahm

Dec 14, 2025

Dec 11, 2025

How Investors May Respond To Capricor Therapeutics (CAPR) Phase 3 HOPE-3 Success And $150 Million Equity Raise - Sahm

Dec 11, 2025

Dec 10, 2025

Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock Offering - Sidley Austin

Dec 10, 2025

Dec 10, 2025

Capricor: A Detailed Examination Of Hope-3 (NASDAQ:CAPR) - Seeking Alpha

Dec 10, 2025

Dec 10, 2025

Piper Sandler Reiterates Overweight Rating on CAPR, Raises Price Target | CAPR Stock News - GuruFocus

Dec 10, 2025

Dec 10, 2025

What Does the Market Think About Capricor Therapeutics Inc? - Benzinga

Dec 10, 2025

Dec 10, 2025

Piper Sandler raises Capricor Therapeutics stock price target to $45 on trial success - Investing.com

Dec 10, 2025

Dec 10, 2025

Biotech Stocks To Add to Your WatchlistDecember 5th - MarketBeat

Dec 10, 2025

Dec 09, 2025

A strong week for data readouts: Clinical Report - BioCentury

Dec 09, 2025

Dec 09, 2025

Capricor's cell therapy shows breakthrough results in Duchenne muscular dystrophy trial - Indian Pharma Post

Dec 09, 2025

Dec 09, 2025

Kennedy Capital Management LLC Reduces Position in Capricor Therapeutics, Inc. $CAPR - MarketBeat

Dec 09, 2025

Dec 08, 2025

Oppenheimer Maintains Capricor Therapeutics (CAPR) Outperform Recommendation - Nasdaq

Dec 08, 2025

Dec 08, 2025

Oppenheimer raises Capricor Therapeutics price target to $54 on positive trial data - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Up 5.8%What's Next? - MarketBeat

Dec 08, 2025

Dec 08, 2025

Stock Traders Purchase High Volume of Call Options on Capricor Therapeutics (NASDAQ:CAPR) - MarketBeat

Dec 08, 2025